Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Prostate Cancer

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 12 articles: HTML format

Single Articles

October 2021
1. VIANI GA, Gouveia AG, Jacinto AA, Moraes FY, et al
   Stereotactic Body Radiotherapy for Prostate Cancer: Where, When, and Who? A Bibliometric Analysis.
   Am J Clin Oncol. 2021 Oct 6. pii: 00000421-900000000-98529.
   PubMed     Abstract available
   
   
   June 2021
2. MERRICK GS, Galbreath R, Fiano R, Scholl W, et al
   The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients.
   Am J Clin Oncol. 2021 Jun 7. pii: 00000421-900000000-98553.
   PubMed     Abstract available
   
   
   May 2021
3. SOLIMAN L, De Souza A, Srinivasan P, Danish M, et al
   The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies.
   Am J Clin Oncol. 2021 May 17. pii: 00000421-900000000-98561.
   PubMed     Abstract available
   
   
   February 2021
4. PALY JJ, Egleston BL, Wong JK, Burbure N, et al
   Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes.
   Am J Clin Oncol. 2021 Feb 9. pii: 00000421-900000000-98595.
   PubMed     Abstract available
   
   
   December 2020
5. WU S, Lin SX, Wirth GJ, Lu M, et al
   Long-term Oncologic Impact of Positive Anterior and Posterior Surgical Margins After Radical Prostatectomy.
   Am J Clin Oncol. 2020;43:872-879.
   PubMed     Abstract available
   
   
   
6. JANZEN BW, Ong A, Penner M, Koul R, et al
   Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate.
   Am J Clin Oncol. 2020;43:865-871.
   PubMed     Abstract available
   
   
   September 2020
7. D'AGOSTINO GR, Mancosu P, Di Brina L, Franzese C, et al
   Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study.
   Am J Clin Oncol. 2020;43:628-635.
   PubMed     Abstract available
   
   
   July 2020
8. MURALIDHAR V, Dee EC, D'Amico AV
   Sequencing Treatments for Cancer During the COVID-19 Pandemic.
   Am J Clin Oncol. 2020;43:457-458.
   PubMed    
   
   
   June 2020
9. LEHRER S, Rheinstein PH
   Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
   Am J Clin Oncol. 2020 Jun 19. doi: 10.1097/COC.0000000000000727.
   PubMed     Abstract available
   
   
   
10. D'AGOSTINO GR, Mancosu P, Di Brina L, Franzese C, et al
    Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study.
    Am J Clin Oncol. 2020 Jun 2. doi: 10.1097/COC.0000000000000721.
    PubMed     Abstract available
    
    
    April 2020
11. PARSAI S, Juloori A, Sedor G, Reddy CA, et al
    Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study.
    Am J Clin Oncol. 2020 Apr 28. doi: 10.1097/COC.0000000000000693.
    PubMed     Abstract available
    
    
    February 2020
12. ADDO-TABIRI NO, Chudasama R, Vasudeva R, Leiva O, et al
    Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.
    Am J Clin Oncol. 2020;43:94-100.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: